Diploma in Pharmacy / Бакалавр (Diploma) в Области Фармацевтического Дела

Course Details

Course Information Package

Course Unit TitleCLINICAL PHARMACY & DRUG INTERACTIONS
Course Unit CodePHA406
Course Unit Details
Number of ECTS credits allocated6
Learning Outcomes of the course unitBy the end of the course, the students should be able to:
  1. Recognise in collaboration with the physician in the hospital ward in problems of pharmacotherapy, of setting the therapeutic scheme, doses, of drug interactions.
  2. Recognise the drugs and their main metabolites in biological fluids.
  3. State fairly well (pharmaco) therapeutics and decision making concerning therapeutic schemes and doses, which could be suggested by the physician.
  4. Analyse the role, which sometimes is important, of age, sex, race, body weight, diet, pregnancy, lactation and various disease conditions.
  5. Analyse the importance and dangers of multidrug therapies.
Mode of DeliveryFace-to-face
PrerequisitesNONECo-requisitesNONE
Recommended optional program componentsNONE
Course ContentsThis course prepares, assisted by the rest of the pharmacy curriculum, a prospective pharmacist, especially clinical pharmacist, to assist and collaborate with the medical doctor in the hospital ward, in problems of pharmacotherapy, setting of therapeutic scheme, drug doses, drug interactions and determination of drug and main drug metabolite levels in biological fluids (blood, urine, feces, cerebrospinal fluid, saliva).The following are included:
·  Principles of pathophysiology of diseases and therapeutics.
·  Approaches in pharmacotherapy, decision of the appropriate therapeutic scheme, drug doses.
·  Role of age, sex, race, body weight, diet, pregnancy, lactation, diabetes, renal, liver heart dysfunctions.
·  Multi drug therapies.
·  Pharmaceutical, pharmacokinetic (absorption, distribution, metabolism excretion), pharmacodynamic drug-drug and drug-food interactions.
·  Correlation of structure and physicochemical properties with therapeutic efficacy and safety of drugs.
·  Chemical analysis, detection and quantitative determination of drugs and drug metabolites in biological fluids.
Laboratory Work: Determination of a drug, e.g. aspirin or paracetamol, and the main metabolite in urine (by GLC or HPLC), Determination of a drug, e.g. quinine or caffeine, in blood, Investigation of the simultaneous administration of a dose (0.1 mg) of digitoxin and of a high dose (1.5 g) of aluminium hydroxide, Investigation of the effect of zoxazolamine, a centrally acting muscle relaxant, administered after a 4-day treatment with Phenobarbital, Series of 2h visit to a hospital ward, with a physician, and discussion with the responsible teacher in the presence of the physician.
Recommended and/or required reading:
Textbooks
  • M. Randall, K. E. Neil, Disease Management: A Guide to Clinical Pharmacology, Pharmaceutical Press, 2009.
  • K. Baxter, Stockley's Drug Interactions Pocket Companion, Pharmaceutical Press, 1st ed., 2010.
References
  • R. Walker, C. Whittlesea, Clinical Pharmacy and Therapeutics, Churchill Livingstone, 4th ed., 2007.
  • D.S. Tatro, Drug Interaction Facts, Lippincott Williams & Wilkins; 1st ed., 2010.
Planned learning activities and teaching methodsThe taught part of course is delivered to the students by means of lectures, conducted with the help of computer presentations. Lecture notes and presentations are available through the web for students to use in combination with the textbooks.
Lectures are supplemented with laboratory work carried out in a pharmaceutical chemistry laboratory.
Assessment methods and criteria
Tests20%
Laboratory work20%
Final Exam60%
Language of instructionGreek
Work placement(s)NO

 Печать  E-mail